KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Direct costs attributable to producing goods sold
5Y CAGR
-12.6%/yr
Long-term compound
Percentile
P77
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $21.10M | - |
| 2025 | $0.00 | -100.0% |
| 2024 | $86.17M | - |
| 2023 | $0.00 | - |
| 2022 | $0.00 | -100.0% |
| 2021 | $41.29M | +2.7% |
| 2020 | $40.19M | +114671.1% |
| 2019 | $35021.00 | +92.0% |
| 2018 | $18237.00 | +44.0% |
| 2017 | $12666.00 | - |